Shopping Cart
- Remove All
- Your shopping cart is currently empty
Laromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity.
Inhibiting thioredoxin reductase can be used to study acute myeloid leukemia.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $293 | In Stock | |
5 mg | $722 | In Stock | |
10 mg | $987 | In Stock | |
25 mg | $1,520 | In Stock | |
50 mg | $1,980 | In Stock |
Description | Laromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity. Inhibiting thioredoxin reductase can be used to study acute myeloid leukemia. |
Targets&IC50 | CYP2B6:125 mM (Ki), CYP2C19:349 mM (ki), CYP3A4/5:297 mM (Ki) |
In vitro | Laromustine caused direct inhibition of CYP2B6 and CYP3A4/5 as well as of CYP2C19. CYP2B6 K(i)=125 mM, CYP3A4/5 K(i)=297 mM, and CYP2C19 K(i)=349 mM and were greater than the average clinical plasma C(max) of Laromustine (C(max)=25 mM). [1] |
Alias | VNP40101M, VNP 40101M |
Molecular Weight | 307.78 |
Formula | C6H14ClN3O5S2 |
Cas No. | 173424-77-6 |
Smiles | O=C(NC)N(N(CCCl)S(=O)(=O)C)S(=O)(=O)C |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.